H. B. Fuller (NYSE:FUL - Get Free Report) was upgraded by analysts at Seaport Res Ptn from a "hold" rating to a "strong-buy" rating in a research report issued on Friday,Zacks.com reports. Seaport Res Ptn also issued estimates for H. B. Fuller's Q3 2027 earnings at $1.49 EPS and FY2027 earnings at $5.37 EPS.
Other equities analysts also recently issued research reports about the company. JPMorgan Chase & Co. increased their price target on H. B. Fuller from $50.00 to $54.00 and gave the company an "underweight" rating in a report on Friday, June 27th. Robert W. Baird increased their price target on H. B. Fuller from $60.00 to $75.00 and gave the company an "outperform" rating in a report on Friday, June 27th. Finally, Citigroup lowered their price target on H. B. Fuller from $70.00 to $62.00 and set a "neutral" rating on the stock in a report on Friday. Two research analysts have rated the stock with a Strong Buy rating, two have given a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the company's stock. According to MarketBeat.com, H. B. Fuller presently has a consensus rating of "Moderate Buy" and a consensus target price of $65.75.
View Our Latest Research Report on FUL
H. B. Fuller Trading Up 2.1%
NYSE:FUL opened at $58.15 on Friday. The stock's 50 day moving average price is $59.67 and its 200 day moving average price is $57.22. H. B. Fuller has a 52 week low of $47.56 and a 52 week high of $81.69. The company has a market capitalization of $3.14 billion, a P/E ratio of 27.82, a P/E/G ratio of 0.95 and a beta of 1.14. The company has a debt-to-equity ratio of 1.06, a quick ratio of 1.15 and a current ratio of 1.93.
H. B. Fuller (NYSE:FUL - Get Free Report) last released its quarterly earnings data on Wednesday, September 24th. The specialty chemicals company reported $1.26 EPS for the quarter, topping analysts' consensus estimates of $1.24 by $0.02. H. B. Fuller had a return on equity of 11.49% and a net margin of 3.28%.The firm had revenue of $892.04 million for the quarter, compared to the consensus estimate of $894.60 million. During the same quarter in the prior year, the company posted $1.13 earnings per share. The firm's revenue was down 2.8% on a year-over-year basis. H. B. Fuller has set its FY 2025 guidance at 4.100-4.250 EPS. On average, research analysts forecast that H. B. Fuller will post 4.07 EPS for the current fiscal year.
Insider Buying and Selling at H. B. Fuller
In other news, VP Robert J. Martsching sold 9,546 shares of the firm's stock in a transaction on Thursday, July 10th. The shares were sold at an average price of $64.30, for a total value of $613,807.80. Following the sale, the vice president owned 14,980 shares in the company, valued at approximately $963,214. This trade represents a 38.92% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, VP Joao Magalhaes sold 1,099 shares of the firm's stock in a transaction on Friday, August 8th. The stock was sold at an average price of $56.31, for a total transaction of $61,884.69. Following the completion of the sale, the vice president owned 3,285 shares in the company, valued at approximately $184,978.35. The trade was a 25.07% decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders sold 11,691 shares of company stock worth $734,478. 1.99% of the stock is currently owned by corporate insiders.
Institutional Inflows and Outflows
Hedge funds and other institutional investors have recently bought and sold shares of the company. Partners Capital Investment Group LLP lifted its position in H. B. Fuller by 90.3% in the first quarter. Partners Capital Investment Group LLP now owns 64,901 shares of the specialty chemicals company's stock worth $3,642,000 after purchasing an additional 30,805 shares during the period. Entropy Technologies LP bought a new position in H. B. Fuller in the first quarter worth $581,000. Neo Ivy Capital Management bought a new position in H. B. Fuller in the first quarter worth $990,000. Quantbot Technologies LP lifted its position in H. B. Fuller by 612.4% in the first quarter. Quantbot Technologies LP now owns 28,083 shares of the specialty chemicals company's stock worth $1,576,000 after purchasing an additional 24,141 shares during the period. Finally, Cooke & Bieler LP bought a new position in H. B. Fuller in the first quarter worth $36,830,000. 95.93% of the stock is owned by institutional investors.
About H. B. Fuller
(
Get Free Report)
H.B. Fuller Company, together with its subsidiaries, formulates, manufactures, and markets adhesives, sealants, coatings, polymers, tapes, encapsulants, additives, and other specialty chemical products. It operates through three segments: Hygiene, Health and Consumable Adhesives; Engineering Adhesives; and Construction Adhesives.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider H. B. Fuller, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and H. B. Fuller wasn't on the list.
While H. B. Fuller currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.